| WNT signaling modulates PD-L1 expression in the stem cell compartment of triple-negative breast cancer L Castagnoli, V Cancila, SL Cordoba-Romero, S Faraci, G Talarico, ... Oncogene 38 (21), 4047-4060, 2019 | 166 | 2019 |
| Hepatic steatosis and insulin resistance are associated with severe fibrosis in patients with chronic hepatitis caused by HBV or HCV infection S Petta, C Cammà, VD Marco, FS Macaluso, M Maida, G Pizzolanti, ... Liver International 31 (4), 507-515, 2011 | 116 | 2011 |
| Gut microbiota condition the therapeutic efficacy of trastuzumab in HER2-positive breast cancer M Di Modica, G Gargari, V Regondi, A Bonizzi, S Arioli, B Belmonte, ... Cancer Research 81 (8), 2195-2206, 2021 | 76 | 2021 |
| Pathogenic role of complement in antiphospholipid syndrome and therapeutic implications F Tedesco, MO Borghi, M Gerosa, CB Chighizola, P Macor, PA Lonati, ... Frontiers in immunology 9, 374767, 2018 | 65 | 2018 |
| Cross-talk between myeloid-derived suppressor cells and mast cells mediates tumor-specific immunosuppression in prostate cancer E Jachetti, V Cancila, A Rigoni, L Bongiovanni, B Cappetti, B Belmonte, ... Cancer immunology research 6 (5), 552-565, 2018 | 53 | 2018 |
| Prognostic implications of the complement protein C1q in gliomas A Mangogna, B Belmonte, C Agostinis, P Zacchi, DG Iacopino, ... Frontiers in immunology 10, 2366, 2019 | 48 | 2019 |
| New landscapes and horizons in hepatocellular carcinoma therapy M Cervello, MR Emma, G Augello, A Cusimano, L Giannitrapani, M Soresi, ... Aging (Albany NY) 12 (3), 3053, 2020 | 46 | 2020 |
| Complement protein C1q binds to hyaluronic acid in the malignant pleural mesothelioma microenvironment and promotes tumor growth C Agostinis, R Vidergar, B Belmonte, A Mangogna, L Amadio, P Geri, ... Frontiers in immunology 8, 1559, 2017 | 45 | 2017 |
| Targeting HSP90 with the small molecule inhibitor AUY922 (luminespib) as a treatment strategy against hepatocellular carcinoma G Augello, MR Emma, A Cusimano, A Azzolina, S Mongiovì, R Puleio, ... International journal of cancer 144 (10), 2613-2624, 2019 | 42 | 2019 |
| Is the complement protein C1q a pro-or anti-tumorigenic factor? Bioinformatics analysis involving human carcinomas A Mangogna, C Agostinis, D Bonazza, B Belmonte, P Zacchi, G Zito, ... Frontiers in immunology 10, 865, 2019 | 41 | 2019 |
| Targeting CD34+ cells of the inflamed synovial endothelium by guided nanoparticles for the treatment of rheumatoid arthritis F Colombo, P Durigutto, L De Maso, S Biffi, B Belmonte, C Tripodo, ... Journal of Autoimmunity 103, 102288, 2019 | 36 | 2019 |
| Evaluation of thermoresponsive properties and biocompatibility of polybenzofulvene aggregates for leuprolide delivery M Licciardi, G Amato, A Cappelli, M Paolino, G Giuliani, B Belmonte, ... International journal of pharmaceutics 438 (1-2), 279-286, 2012 | 32 | 2012 |
| Pathological significance and prognostic value of surfactant protein D in cancer A Mangogna, B Belmonte, C Agostinis, G Ricci, A Gulino, I Ferrara, ... Frontiers in Immunology 9, 1748, 2018 | 22 | 2018 |
| The PDGFRβ/ERK1/2 pathway regulates CDCP1 expression in triple-negative breast cancer L Forte, F Turdo, C Ghirelli, P Aiello, P Casalini, MV Iorio, E D’Ippolito, ... BMC cancer 18, 1-11, 2018 | 21 | 2018 |
| Interleukin-31 and thymic stromal lymphopoietin expression in plasma and lymph node from Hodgkin lymphoma patients E Ferretti, S Hohaus, A Di Napoli, B Belmonte, A Cuccaro, E Cupelli, ... Oncotarget 8 (49), 85263, 2017 | 19 | 2017 |
| Direct RNA nanopore sequencing of SARS-CoV-2 extracted from critical material from swabs D Vacca, A Fiannaca, F Tramuto, V Cancila, L La Paglia, W Mazzucco, ... Life 12 (1), 69, 2022 | 18 | 2022 |
| Targeting COPZ1 non-oncogene addiction counteracts the viability of thyroid tumor cells MC Anania, E Cetti, D Lecis, K Todoerti, A Gulino, G Mauro, T Di Marco, ... Cancer letters 410, 201-211, 2017 | 17 | 2017 |
| Genetic and epigenetic factors of Takotsubo syndrome: a systematic review V Ferradini, D Vacca, B Belmonte, R Mango, L Scola, G Novelli, ... International Journal of Molecular Sciences 22 (18), 9875, 2021 | 16 | 2021 |
| C3 drives inflammatory skin carcinogenesis independently of C5 WD Jackson, A Gulino, L Fossati-Jimack, RC Seoane, K Tian, K Best, ... Journal of Investigative Dermatology 141 (2), 404-414. e6, 2021 | 16 | 2021 |
| Therapeutic afucosylated monoclonal antibody and bispecific T-cell engagers for T-cell acute lymphoblastic leukemia D Caracciolo, C Riillo, A Ballerini, G Gaipa, L Lhermitte, M Rossi, C Botta, ... Journal for immunotherapy of cancer 9 (2), 2021 | 16 | 2021 |
